226 related articles for article (PubMed ID: 6210797)
21. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
[TBL] [Abstract][Full Text] [Related]
22. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
23. Reactivity of lymphocytes from primary neoplasms of lymphoid tissues.
Twomey JJ; Laughter AH; Lazar S; Douglass CC
Cancer; 1976 Aug; 38(2):740-7. PubMed ID: 135638
[TBL] [Abstract][Full Text] [Related]
24. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
Han T
Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
[TBL] [Abstract][Full Text] [Related]
25. Monocyte function in Hodgkin's disease.
Holm G; Björkholm M; Johansson B; Mellstedt H; Lindemalm C
Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
[TBL] [Abstract][Full Text] [Related]
26. Blood B and T lymphocytes and in vitro cellular immune reactivity in untreated human malignant lymphomas and other malignant tumors.
Heier HE; Klepp R; Gundersen S; Godal T; Normann T
Scand J Haematol; 1977 Feb; 18(2):137-48. PubMed ID: 138931
[TBL] [Abstract][Full Text] [Related]
27. High numbers of CD4+ T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin's disease.
Maggi E; Parronchi P; Macchia D; Bellesi G; Romagnani S
Blood; 1988 May; 71(5):1503-6. PubMed ID: 2965930
[TBL] [Abstract][Full Text] [Related]
28. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
Cohnen G
Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin's disease. An immunodepleting and immunosuppressive disorder.
Twomey JJ; Laughter AH; Farrow S; Douglass CC
J Clin Invest; 1975 Aug; 56(2):467-75. PubMed ID: 125290
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
31. Diminished autologous mixed lymphocyte reaction in patients with Hodgkin disease: evidence for non-T cell dysfunction.
Zamkoff KW; Dock NL; Kurec AS; Davey FR
Am J Hematol; 1982 Jun; 12(4):327-35. PubMed ID: 6214184
[TBL] [Abstract][Full Text] [Related]
32. Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease.
Lang JM; Oberling F; Bigel P; Mayer S; Waitz R
Biomedicine; 1974 Sep; 21(9):372-7. PubMed ID: 4281669
[No Abstract] [Full Text] [Related]
33. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
34. MLC stimulatory capacity and production of blastogenic factor in patients with chronic lymphatic leukemia and Hodgkin's disease.
Kasakura S
Blood; 1975 Jun; 45(6):823-32. PubMed ID: 123801
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte function in patients with Hodgkin's disease.
Rühl H; Vogt W; Rühl U
G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
[TBL] [Abstract][Full Text] [Related]
36. Impairment of T lymphocyte colony formation in Hodgkin's disease: effect of soluble inhibitory factors on normal T lymphocyte colony formation potential.
Mukhopadhyaya R; Advani SH; Gangal SG
Acta Haematol; 1983; 70(6):357-63. PubMed ID: 6417959
[TBL] [Abstract][Full Text] [Related]
37. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
Fisher RI
Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.
Gorski AJ; Dupont B; Hansen JA; Safai B; Pahwa S; Good RA
J Immunol; 1977 Mar; 118(3):858-62. PubMed ID: 139447
[TBL] [Abstract][Full Text] [Related]
39. Deficient helper cell function as a cause of diminished pokeweed mitogen blastogenic responses in patients with non-Hodgkin's lymphomas.
Silver BA; Bostick-Bruton FW; Neckers L; Fisher RI
Cancer; 1984 Dec; 54(12):2936-42. PubMed ID: 6238671
[TBL] [Abstract][Full Text] [Related]
40. Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
Vánky F; Gorsky T; Gorsky Y; Masucci MG; Klein E
J Exp Med; 1982 Jan; 155(1):83-95. PubMed ID: 6459402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
